Improvement of Dissolution and Bioavailability of Nitrendipine by Inclusion in Hydroxypropyl-?-cyclodextrin
- 1 January 2003
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 29 (10), 1085-1094
- https://doi.org/10.1081/ddc-120025866
Abstract
A significant increase in solubility and dissolution rate of nitrendipine, a slightly soluble calcium channel blocker, was achieved by inclusion complexation with hydroxypropyl-beta-cyclodextrin (HP-beta-CD). The inclusion complex was prepared by solvent evaporation method and characterized by phase solubility method, x-ray diffractometry, infrared spectroscopy, and differential scanning calorimetry. The solubility of nitrendipine increased linearly as a function of HP-beta-CD concentration, resulting in AL-type phase solubility diagram which revealed a formation of inclusion complex in a molar ratio of 1:1, with the apparent association constant of 108.3M(-1). The in vitro dissolution rate of nitrendipine in pH 7.4 phosphate buffer was in the order of inclusion complex, physical mixture, and nitrendipine powder. These three different forms of nitrendipine were administered orally to rats with a dose of 10 mg/kg equivalent to nitrendipine. The AUC of inclusion complex was significantly larger than that of nitrendipine powder. Tmax of inclusion complex was significantly shorter and Cmax was significantly higher than those of nitrendipine powder. Cmax of physical mixture was higher than that of nitrendipine powder. Tmax of physical mixture, however, remained the same. The results indicated that the bioavailability of nitrendipine could be improved markedly by inclusion complexation, possibly due to an increased dissolution rate.Keywords
This publication has 33 references indexed in Scilit:
- Study of the inclusion complex of atenolol with β-cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Evaluation of a hydrocortisone/hydroxypropyl-β-cyclodextrin solution for ocular drug deliveryInternational Journal of Pharmaceutics, 1997
- Pharmacokinetic profile of piroxicam β-cyclodextrin, in rat plasma and lymphGeneral Pharmacology: The Vascular System, 1997
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996
- Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrinInternational Journal of Pharmaceutics, 1991
- Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrinsInternational Journal of Pharmaceutics, 1988
- Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitorsPediatric Cardiology, 1988
- Characterization, Dissolution and Diffusion Properties of Tolbutamide-β-Cyclodextrin Complex SystemDrug Development and Industrial Pharmacy, 1988
- NitrendipineDrugs, 1987
- Disposition and Pharmacokinetics of 14C-Nitrendipine in Healthy VolunteersJournal of Cardiovascular Pharmacology, 1987